Pimentel, F. F. (2021) “SYNERGISTIC MECHANISMS OF ACTION: COMPARISON OF ADCC AND SIGNALING PATHWAYS INHIBITION BY TRASTUZUMAB BIOSIMILAR OR ORIGINATOR TRASTUZUMAB IN COMBINATION WITH PERTUZUMAB IN HER2+ BREAST CANCER CELL LINES”, Mastology. Rio de Janeiro, 31, p. 9. Disponível em: https://revistamastology.emnuvens.com.br/revista/article/view/981 (Acessado: 12 outubro 2025).